Earnings call transcript: COFACE Q3 2026 profit holds firm as growth improves

COFACE reported EUR 155 million of net profit for the first nine months of 2026, including about EUR 48 million in Q3; revenue grew 5.4% in Q3 at constant exchange rates and scope. The nine-month net combined ratio was 72.4%, below the 78% through-the-cycle target, while record new-business production and growing service revenue supported the outlook. However, net income fell 11.8% year over year, and management cited record insolvencies, larger claims, investment-related cost pressure and interest-rate effects on solvency; shares were up 0.83% at $15.73.

Analysis

The key earnings-quality issue is the gap between current underwriting and reported profitability: large claims are beginning to emerge, while favorable development from prior vintages is cushioning the loss ratio. If those reserve releases fade as severity rises, the combined ratio can worsen faster than headline revenue growth implies. Watch new-vintage loss performance and reserve development separately at the February results.

There is also a timing mismatch in the investment case. Distribution and data spending hits costs now; management says new hires may take about three years to reach full productivity, while meaningful operational AI savings remain unproven. Service growth may diversify revenue, but it has not yet demonstrated that it can offset claims volatility or investment costs through a downturn. Allianz Trade and Atradius could gain if COFACE curtails investment, though that response would sacrifice future distribution and data capabilities.

For the next 1–3 months, the catalysts are Q4 claims/severity, reserve releases, cost-ratio progression and solvency disclosures. Over 6–18 months, higher reinvestment yields could support recurring income, but only gradually; in the near term, rising yields can depress fixed-income marks and solvency while also stressing insured corporates. The contrarian risk is treating the current low combined ratio as a durable earnings floor rather than a cycle-sensitive outcome. The reported modest share reaction offers no clear evidence of mispricing, and the supplied data do not support a valuation-based target.

Key Decisions for Investors

• No immediate directional trade: avoid chasing the mildly positive update until current-vintage claims and reserve development are clearer.
• Set a February-results alert for gross/new-vintage loss ratio, prior-year reserve releases, net cost ratio and solvency. A deterioration in claims alongside fading releases would weaken the earnings-quality thesis.
• Consider a conditional long only if underwriting remains resilient without relying on reserve releases and service growth begins to absorb investment costs; reassess if the combined ratio trends toward or above the 78% through-cycle target.
• Do not underwrite a near-term AI productivity catalyst. Treat improving recurring investment income as a medium-term offset, not a hedge against immediate solvency or claims shocks.